{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:18:20Z","timestamp":1792498700982,"version":"4.5.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Host & Microbe"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.chom.2025.10.005","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T15:02:31Z","timestamp":1761836551000},"page":"1837-1854.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Bioengineered gut bacterium synthesizing levodopa alleviates motor deficits in models of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Piyush","family":"Padhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Backes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa A.","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileia J.","family":"Scheibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gargi","family":"Khadse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manikandan","family":"Samidurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander K.","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Zenitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vellareddy","family":"Anantharam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthi","family":"Kanthasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Allenspach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Mochel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6454-4264","authenticated-orcid":false,"given":"Anumantha G.","family":"Kanthasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chom.2025.10.005_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson Pandemic-A Call to Action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.chom.2025.10.005_bib2","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1212\/WNL.0000000000002510","article-title":"Advances in levodopa therapy for Parkinson disease: Review of RYTARY (carbidopa and levodopa) clinical efficacy and safety","volume":"86","author":"Dhall","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.chom.2025.10.005_bib3","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/466S6a","article-title":"Levodopa: the story so far","volume":"466","author":"Abbott","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.chom.2025.10.005_bib4","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson\u2019s disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.chom.2025.10.005_bib5","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1093\/brain\/awaa181","article-title":"Natural history of motor symptoms in Parkinson\u2019s disease and the long-duration response to levodopa","volume":"143","author":"Cilia","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.chom.2025.10.005_bib6","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/S0140-6736(14)60683-8","article-title":"Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson\u2019s disease (PD MED): a large, open-label, pragmatic randomised trial","volume":"384","author":"Gray","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.chom.2025.10.005_bib7","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2174\/1570159X15666170510143821","article-title":"Levodopa in Parkinson\u2019s Disease: Current Status and Future Developments","volume":"16","author":"Tambasco","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ana.25364","article-title":"Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts","volume":"84","author":"Espay","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.chom.2025.10.005_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/187152706777452245","article-title":"D1 and functionally selective dopamine agonists as neuroprotective agents in Parkinson\u2019s disease","volume":"5","author":"Lewis","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.chom.2025.10.005_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe5948","article-title":"Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA-induced dyskinesia","volume":"7","author":"Fridjonsdottir","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.chom.2025.10.005_bib11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/brain\/awh102","article-title":"Presynaptic mechanisms of motor fluctuations in Parkinson\u2019s disease: a probabilistic model","volume":"127","author":"de la Fuente-Fern\u00e1ndez","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.chom.2025.10.005_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.parkreldis.2021.09.024","article-title":"ND0612 (levodopa\/carbidopa for subcutaneous infusion) in patients with Parkinson\u2019s disease and motor response fluctuations: A randomized, placebo-controlled phase 2 study","volume":"91","author":"Giladi","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.chom.2025.10.005_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archneur.62.6.905","article-title":"Intermittent vs continuous levodopa administration in patients with advanced Parkinson disease: a clinical and pharmacokinetic study","volume":"62","author":"Stocchi","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.chom.2025.10.005_bib14","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1212\/WNL.0000000000001500","article-title":"Causes of withdrawal of duodenal levodopa infusion in advanced Parkinson disease","volume":"84","author":"Calandrella","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.chom.2025.10.005_bib15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JPD-202285","article-title":"Continuous Subcutaneous Levodopa Delivery for Parkinson\u2019s Disease: A Randomized Study","volume":"11","author":"Olanow","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.chom.2025.10.005_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1474-4422(24)00052-8","article-title":"Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson\u2019s disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial","volume":"23","author":"Espay","year":"2024","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.chom.2025.10.005_bib17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nbt.4222","article-title":"Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria","volume":"36","author":"Isabella","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.chom.2025.10.005_bib18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41551-022-00871-9","article-title":"An engineered live biotherapeutic for the prevention of antibiotic-induced dysbiosis","volume":"6","author":"Cubillos-Ruiz","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.chom.2025.10.005_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111112","article-title":"Apyrase-mediated amplification of secretory IgA promotes intestinal homeostasis","volume":"40","author":"Perruzza","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.chom.2025.10.005_bib20","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.4161\/hv.34378","article-title":"ADXS-HPV: a therapeutic Listeria vaccination targeting cervical cancers expressing the HPV E7 antigen","volume":"10","author":"Cory","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.chom.2025.10.005_bib21","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.3748\/wjg.v22.i24.5505","article-title":"Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update","volume":"22","author":"Scaldaferri","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.chom.2025.10.005_bib22","first-page":"587","article-title":"Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)","volume":"89","author":"M\u00f6llenbrink","year":"1994","journal-title":"Med. Klin. (Munich)"},{"key":"10.1016\/j.chom.2025.10.005_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.836605","article-title":"Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders","volume":"16","author":"Padhi","year":"2022","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.chom.2025.10.005_bib24","doi-asserted-by":"crossref","first-page":"22823","DOI":"10.1016\/S0021-9258(17)31719-2","article-title":"Molecular characterization of 4-hydroxyphenylacetate 3-hydroxylase of Escherichia coli. A two-protein component enzyme","volume":"269","author":"Prieto","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chom.2025.10.005_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.syapm.2005.07.012","article-title":"Bacterial tyrosinases","volume":"29","author":"Claus","year":"2006","journal-title":"Syst. Appl. Microbiol."},{"key":"10.1016\/j.chom.2025.10.005_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1146\/annurev.arplant.50.1.473","article-title":"The Shikimate Pathway","volume":"50","author":"Herrmann","year":"1999","journal-title":"Annu. Rev. Plant Physiol. Plant Mol. Biol."},{"key":"10.1016\/j.chom.2025.10.005_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1615\/CritRevEukaryotGeneExpr.v14.i12.30","article-title":"SCE jumping: genetic tool for allelic exchange in bacteria","volume":"14","author":"Wong","year":"2004","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.chom.2025.10.005_bib28","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1073\/pnas.97.18.10191","article-title":"Genetic footprinting with mariner-based transposition in Pseudomonas aeruginosa","volume":"97","author":"Wong","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2025.10.005_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/cts.12528","article-title":"Translational Development of Microbiome-Based Therapeutics: Kinetics of E. coli Nissle and Engineered Strains in Humans and Nonhuman Primates","volume":"11","author":"Kurtz","year":"2018","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.chom.2025.10.005_bib30","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/s42255-021-00430-7","article-title":"Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1\/2a study","volume":"3","author":"Puurunen","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.chom.2025.10.005_bib31","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2025.10.005_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113716","article-title":"Characterization of nonmotor behavioral impairments and their neurochemical mechanisms in the MitoPark mouse model of progressive neurodegeneration in Parkinson\u2019s disease","volume":"341","author":"Langley","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.chom.2025.10.005_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6323","article-title":"Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism","volume":"364","author":"Maini Rekdal","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.chom.2025.10.005_bib34","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","article-title":"Dopamine System Dysregulation in Major Depressive Disorders","volume":"20","author":"Belujon","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.982218","article-title":"Longitudinal assessment of motor function following the unilateral intrastriatal 6-hydroxydopamine lesion model in mice","volume":"16","author":"Sun","year":"2022","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.chom.2025.10.005_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111530","article-title":"Unilateral Intrastriatal 6-Hydroxydopamine Lesion in Mice: A Closer Look into Non-Motor Phenotype and Glial Response","volume":"22","author":"Mendes-Pinheiro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chom.2025.10.005_bib37","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3390\/biomedicines9060598","article-title":"A Guide to the Generation of a 6-Hydroxydopamine Mouse Model of Parkinson\u2019s Disease for the Study of Non-Motor Symptoms","volume":"9","author":"Masini","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.chom.2025.10.005_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.chom.2025.10.005_bib39","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3390\/cells11061032","article-title":"Lipopolysaccharide-Induced Strain-Specific Differences in Neuroinflammation and MHC-I Pathway Regulation in the Brains of Bl6 and 129Sv Mice","volume":"11","author":"Piirsalu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.chom.2025.10.005_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fphar.2020.00371","article-title":"Treatment With Lipopolysaccharide Induces Distinct Changes in Metabolite Profile and Body Weight in 129Sv and Bl6 Mouse Strains","volume":"11","author":"Piirsalu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.4049\/jimmunol.168.2.869","article-title":"129X1\/SvJ mouse strain has a novel defect in inflammatory cell recruitment","volume":"168","author":"White","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.chom.2025.10.005_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/srep17324","article-title":"Escherichia coli Nissle 1917 enhances bioavailability of serotonin in gut tissues through modulation of synthesis and clearance","volume":"5","author":"Nzakizwanayo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chom.2025.10.005_bib43","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1476-5381.2009.00270.x","article-title":"A probiotic strain of Escherichia coli, Nissle 1917, given orally exerts local and systemic anti-inflammatory effects in lipopolysaccharide-induced sepsis in mice","volume":"157","author":"Arribas","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib44","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1128\/JB.184.21.5912-5925.2002","article-title":"A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917","volume":"184","author":"Grozdanov","year":"2002","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.chom.2025.10.005_bib45","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1128\/IAI.00218-10","article-title":"Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host","volume":"78","author":"Gronbach","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2025.10.005_bib46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tem.2017.01.003","article-title":"Lipocalin-2: A Master Mediator of Intestinal and Metabolic Inflammation","volume":"28","author":"Moschen","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.chom.2025.10.005_bib47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2015.08.007","article-title":"Innate and Adaptive Humoral Responses Coat Distinct Commensal Bacteria with Immunoglobulin A","volume":"43","author":"Bunker","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.chom.2025.10.005_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4877","article-title":"Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy","volume":"7","author":"Kau","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2025.10.005_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.immuni.2018.08.004","article-title":"Antibodies Set Boundaries Limiting Microbial Metabolite Penetration and the Resultant Mammalian Host Response","volume":"49","author":"Uchimura","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.chom.2025.10.005_bib50","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1126\/science.1188454","article-title":"Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses","volume":"328","author":"Hapfelmeier","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.chom.2025.10.005_bib51","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.3390\/microorganisms8111715","article-title":"The Influence of Probiotics on the Firmicutes\/Bacteroidetes Ratio in the Treatment of Obesity and Inflammatory Bowel disease","volume":"8","author":"Stojanov","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.chom.2025.10.005_bib52","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.chom.2025.10.005_bib53","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1023\/A:1016353705970","article-title":"Comparison of canine and human gastrointestinal physiology","volume":"3","author":"Dressman","year":"1986","journal-title":"Pharm. Res."},{"key":"10.1016\/j.chom.2025.10.005_bib54","series-title":"StatPearls","article-title":"Levodopa (L-Dopa)","author":"Gandhi","year":"2022"},{"key":"10.1016\/j.chom.2025.10.005_bib55","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/gutjnl-2019-320204","article-title":"Interaction between drugs and the gut microbiome","volume":"69","author":"Weersma","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.chom.2025.10.005_bib56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/jpet.114.216317","article-title":"The molecular mechanism of intestinal levodopa absorption and its possible implications for the treatment of Parkinson\u2019s disease","volume":"351","author":"Camargo","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.chom.2025.10.005_bib57","doi-asserted-by":"crossref","first-page":"e2443","DOI":"10.1212\/WNL.0000000000201204","article-title":"Association Between Microbial Tyrosine Decarboxylase Gene and Levodopa Responsiveness in Patients With Parkinson Disease","volume":"99","author":"Zhang","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.chom.2025.10.005_bib58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.15698\/mic2018.05.628","article-title":"Microbial wars: Competition in ecological niches and within the microbiome","volume":"5","author":"Bauer","year":"2018","journal-title":"Microb. Cell"},{"key":"10.1016\/j.chom.2025.10.005_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00496-22","article-title":"Identification of Multiple Iron Uptake Mechanisms in Enterococcus faecalis and Their Relationship to Virulence","volume":"91","author":"Brunson","year":"2023","journal-title":"Infect. Immun."},{"key":"10.1016\/j.chom.2025.10.005_bib60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.chom.2013.06.007","article-title":"Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron","volume":"14","author":"Deriu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2025.10.005_bib61","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1128\/JB.02443-14","article-title":"Hydrazidase, a novel amidase signature enzyme that hydrolyzes acylhydrazides","volume":"197","author":"Oinuma","year":"2015","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.chom.2025.10.005_bib62","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3389\/fmicb.2015.00820","article-title":"Bacterial degradation of monocyclic aromatic amines","volume":"6","author":"Arora","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.chom.2025.10.005_bib63","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2125.1986.tb02913.x","article-title":"The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson\u2019s disease who exhibit on-off fluctuations","volume":"22","author":"Hardie","year":"1986","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib64","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/jcph.514","volume":"55","author":"Hsu","year":"2015","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib65","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1016\/j.cell.2022.06.050","article-title":"Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes","volume":"185","author":"Russell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.chom.2025.10.005_bib66","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.chom.2019.02.005","article-title":"Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut","volume":"25","author":"Crook","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.chom.2025.10.005_bib67","article-title":"Gut microbiome dysbiosis across early Parkinson\u2019s disease, REM sleep behavior disorder and their first-degree relatives","volume":"14","author":"Huang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.chom.2025.10.005_bib68","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1093\/brain\/awab156","article-title":"The role of gut dysbiosis in Parkinson\u2019s disease: mechanistic insights and therapeutic options","volume":"144","author":"Wang","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.chom.2025.10.005_bib69","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.chom.2025.10.005_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7975","article-title":"An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans","volume":"11","author":"Kurtz","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2025.10.005_bib71","first-page":"122","article-title":"The non-pathogenic Escherichia coli strain Nissle 1917 \u2013 features of a versatile probiotic","volume":"21","author":"Sonnenborn","year":"2009","journal-title":"Microb. Ecol. Health Dis."},{"key":"10.1016\/j.chom.2025.10.005_bib72","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13036-025-00479-y","article-title":"Engineering probiotic Escherichia coli for inflammation-responsive indoleacetic acid production using RiboJ-enhanced genetic circuits","volume":"19","author":"Woo","year":"2025","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.chom.2025.10.005_bib73","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2125.1989.tb03506.x","article-title":"The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa","volume":"28","author":"Robertson","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib74","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.brainres.2015.06.005","article-title":"L-Dopa induced dyskinesias in Parkinsonian mice: Disease severity or L-Dopa history","volume":"1618","author":"Shan","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.chom.2025.10.005_bib75","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1016\/j.celrep.2018.05.059","article-title":"Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia","volume":"23","author":"Ryan","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.chom.2025.10.005_bib76","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00702-018-1847-7","article-title":"Signal transduction in L-DOPA-induced dyskinesia: from receptor sensitization to abnormal gene expression","volume":"125","author":"Spigolon","year":"2018","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.chom.2025.10.005_bib77","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13041-024-01092-8","article-title":"L-DOPA regulates neuroinflammation and Abeta pathology through NEP and ADAM17 in a mouse model of AD","volume":"17","author":"Lee","year":"2024","journal-title":"Mol. Brain"},{"key":"10.1016\/j.chom.2025.10.005_bib83","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.joen.2006.02.031","article-title":"Detection and quantitation of E. faecalis by real-time PCR (qPCR), reverse transcription-PCR (RT-PCR), and cultivation during endodontic treatment","volume":"32","author":"Williams","year":"2006","journal-title":"J. Endod."},{"key":"10.1016\/j.chom.2025.10.005_bib80","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1472-6750-14-84","article-title":"A versatile and highly efficient method for scarless genome editing in Escherichia coli and Salmonella enterica","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.chom.2025.10.005_bib78","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.plasmid.2011.07.007","article-title":"Vectors for ligation-independent construction of lacZ gene fusions and cloning of PCR products using a nicking endonuclease","volume":"66","author":"Oster","year":"2011","journal-title":"Plasmid"},{"key":"10.1016\/j.chom.2025.10.005_bib79","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.120163297","article-title":"One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products","volume":"97","author":"Datsenko","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.chom.2025.10.005_bib82","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41396-020-00751-7","article-title":"The initial inoculation ratio regulates bacterial coculture interactions and metabolic capacity","volume":"15","author":"Gao","year":"2021","journal-title":"ISME J."},{"key":"10.1016\/j.chom.2025.10.005_bib81","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/WNF.0b013e31825645d1","article-title":"Pharmacokinetics of levodopa\/carbidopa microtablets versus levodopa\/benserazide and levodopa\/carbidopa in healthy volunteers","volume":"35","author":"Nyholm","year":"2012","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib84","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00002826-200305000-00010","article-title":"Optimizing levodopa pharmacokinetics: intestinal infusion versus oral sustained-release tablets","volume":"26","author":"Nyholm","year":"2003","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib85","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000116173","article-title":"Bioavailability of L-dopa after Madopar HBS administration in healthy volunteers","volume":"27","author":"Crevoisier","year":"1987","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.chom.2025.10.005_bib86","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal Propagation of Pathologic alpha-Synuclein from the Gut to the Brain Models Parkinson\u2019s Disease","volume":"103","author":"Kim","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.chom.2025.10.005_bib87","first-page":"Unit 8.12","article-title":"Motor coordination and balance in rodents","volume":"Chapter 8","author":"Carter","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.chom.2025.10.005_bib88","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4066","article-title":"Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice","volume":"10","author":"Gordon","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.chom.2025.10.005_bib89","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1111\/nmo.12070","article-title":"Effects of oral administration of rotenone on gastrointestinal functions in mice","volume":"25","author":"Tasselli","year":"2013","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.chom.2025.10.005_bib90","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.physbeh.2016.02.007","article-title":"Time-dependent behavioral, neurochemical, and metabolic dysregulation in female C57BL\/6 mice caused by chronic high-fat diet intake","volume":"157","author":"Krishna","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.chom.2025.10.005_bib91","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/nprot.2016.091","article-title":"Analysis of bacterial-surface-specific antibodies in body fluids using bacterial flow cytometry","volume":"11","author":"Moor","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.chom.2025.10.005_bib92","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00005344-198011000-00008","article-title":"Evaluation of the effect of dopamine and other catecholamines on the electrocardiogram and blood pressure of rats by means of on-line biosignal processing","volume":"2","author":"Buschmann","year":"1980","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib93","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.chom.2025.10.005_bib94","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1089\/ars.2016.6905","article-title":"Mito-Apocynin Prevents Mitochondrial Dysfunction, Microglial Activation, Oxidative Damage, and Progressive Neurodegeneration in MitoPark Transgenic Mice","volume":"27","author":"Langley","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.chom.2025.10.005_bib95","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/psp4.12141","article-title":"Modeling of Large Pharmacokinetic Data Using Nonlinear Mixed-Effects: A Paradigm Shift in Veterinary Pharmacology. A Case Study With Robenacoxib in Cats","volume":"5","author":"Pelligand","year":"2016","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.chom.2025.10.005_bib96","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.pa.32.040192.001153","article-title":"Population pharmacokinetics\/dynamics","volume":"32","author":"Sheiner","year":"1992","journal-title":"Annu. Rev. Pharmacol. Toxicol."}],"container-title":["Cell Host & Microbe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312825004196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931312825004196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:17:29Z","timestamp":1764163049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931312825004196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1931312825004196"],"URL":"https:\/\/doi.org\/10.1016\/j.chom.2025.10.005","relation":{},"ISSN":["1931-3128"],"issn-type":[{"value":"1931-3128","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioengineered gut bacterium synthesizing levodopa alleviates motor deficits in models of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Cell Host & Microbe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chom.2025.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}